| Trial ID: | L0916 |
| Source ID: | NCT01940263
|
| Associated Drug: |
Anthocyanin
|
| Title: |
Effects of Purified Anthocyanin on Oxidative and Inflammatory Markers in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blinded, Placebo-Controlled Trial
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Fatty Liver Disease
|
| Interventions: |
Dietary Supplement: Anthocyanin;Dietary Supplement: Placebo
|
| Outcome Measures: |
Biomarkers related to oxidative stressBiomarkers related to inflammation
|
| Sponsor/Collaborators: |
Shaoguan University
|
| Gender: |
All
|
| Age: |
18 Years65 Years
|
| Phases: |
Phase 0
|
| Enrollment: |
63
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
|
| Start Date: |
02/09/2013
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
19 February 2015
|
| Locations: |
China
|
| URL: |
http://clinicaltrials.gov/show/NCT01940263
|
